Outcomes in patients undergoing embryo transfer: a systematic review and meta-analysis.

Fecha de publicación: 12/04/2023 Fecha Ahead of Print: 01/04/2023

Autores de IIS La Fe

• José María Rubio Rubio

  Autor

Participantes ajenos a IIS La Fe

• Zolfaroli, Irene
• Monzo Miralles, Ana
• Hidalgo-Mora, Juan Jose
• Marcos Puig, Beatriz

Grupos

• Medicina Reproductiva

  

  Investigador Principal

  José Morales Roselló

Abstract

To analyze the influence of endometrial receptivity analysis (ERA) on embryo transfer (ET) results in patients undergoing in vitro fertilization (IVF) treatment. PubMed, Embase, Cochrane Central Register of Controlled Trials, and BioMed Central databases were searched from inception up to December 2022 for studies comparing pregnancy outcomes in patients undergoing personalized embryo transfer (pET) by ERA versus standard ET. Data were pooled by meta-analysis using a random effects model. We identified twelve studies, including 14,224 patients. No differences were observed between patients undergoing ERA test and those not undergoing ERA test prior to ET in terms of live birth (OR 1.00, 95% CI 0.63-1.58, I2 = 92.7%), clinical pregnancy (OR 1.20, 95% CI 0.90-1.61, I2 = 86.5%), biochemical pregnancy (OR 0.83, 95% CI 0.46-1.49, I2 = 87%), positive pregnancy test (OR 0.99, 95% CI 0.80-1.22, I2 = 0%), miscarriage (OR 0.91, 95% CI 0.62-1.34, I2 = 67.1%), and implantation rate (OR 1.18, 95% CI 0.44-3.14, I2 = 93.2%). pET with ERA is not associated with any significant differences in pregnancy outcomes as compared to standard ET protocols. Therefore, the utility of ERA in patients undergoing IVF should be revisited.

© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Keywords

• Endometrial receptivity analysis; Assisted reproductive technology; Embryo transfer; In vitro fertility; Endometrial receptivity